Tag: biotech funding
OMass raises $310M to take on Vertex in adrenal disease
Oxford-based OMass Therapeutics has raised $310 million in Series C financing, the second-largest private biotech round in Europe this year.
Drylab raises $3M to let AI agents run experiments unattended
A $3M seed round has been raised by Drylab AI, led by Vertex Ventures Southeast Asia and India, with patent…
BigHat’s robot lab reaches the clinic on a $75M round
BigHat's Milliner platform pairs frontier models with automated lab work, and its first antibody-drug conjugate is now in patients.
Basecamp Research targets DNA editing from inside the body
The London biotech's Series C values it at $800 million and funds EDEN models aimed at rewriting a patient's cells…
Enveda lands $311M to move three medicines into late-stage trials
Enveda closed a $311 million Series E led by Catalio to push three clinical-stage medicines deeper into development.
AbbVie signs a multi-year AI deal as Iambic files for Nasdaq
The San Diego drug designer lands a large pharma partner days before asking public investors to fund its pipeline.
Mithrl raises $20M for a biomedical world model aimed at R&D
The company says its platform can cut the time from a research idea to an investigational new drug filing by…
Aureka banks $100M Series B for biology foundation models
Aureka closes a $100M Series B to train biological foundation models for AI-driven drug discovery.